CAC 40 Stabilizes as Markets Await Federal Reserve Decision

Paris Market Stalls Awaiting Fed Decision

Wednesday's session is characterized by a near-paralysis of trading, as investors are hesitant to take clear positions ahead of the Federal Reserve's decision. This event is part of a broader consolidation trend that the CAC 40 has been experiencing now for ten consecutive days, during which the index has been regularly fluctuating within a range between 8,050 and 8,150 points. This stagnation corridor, observable since November 25, is not necessarily a symptom of a slowdown in the upward momentum initiated in recent months. Analysts rather see it as natural profit-taking following a rapid rise largely driven by the technology, consumer, and semiconductor sectors. This pause comes at a time when equity markets are awaiting the Fed's latest decision in 2025, which is expected to result in a third rate cut in three months, marking another step in the US monetary easing cycle that has significantly fueled the stock rally in recent months. European markets are following this wait-and-see approach, with the EuroStoxx 50 dropping 0.25% in turn. This displayed caution should not overshadow certain reallocation movements within portfolios, where stocks benefiting from positive catalysts are beginning to stand out.

Société Générale Leads the Winners Following UBS Approval

Among the stocks standing out, Société Générale emerges as the strongest performer in the CAC 40, gaining 0.70%. The stock of the company based in the La Défense district continues its upward trajectory for a third consecutive session, supported by UBS, which on Tuesday reiterated its buy recommendation while raising its price target from 62 to 70 euros. This positive catalyst was enough to convince traders of the stock's potential in a market where banking stocks remain in the spotlight, particularly given expectations regarding the trajectory of interest rates. Société Générale is not the only one advancing: Unibail-Rodamco-Westfield gains 0.64%, Carrefour moves up by 0.63%, Bureau Veritas by 0.55%, and Eurofins Scientific by 0.46%. These moderate gains reflect investors' appetite for defensive stocks or those with strong fundamentals. Among the winning stocks, the gains remain contained, showing a marked preference for caution. Other CAC 40 giants like L'Oréal, TotalEnergies, or EssilorLuxottica are practically stagnant, barely rising by 0.04% to 0.14%. This fragmented market leadership indicates a redistribution of investments rather than a true widespread buying dynamic.

Strategic Divestments Shape the Sector with Thales Leading the Way

Conversely, stocks in decline quantitatively dominate the stock market board, with Thales leading the way, dropping 2.79%. The defense and aerospace group experiences this decline following its strong performances the previous day, as investors logically take profits in the wake of optimism generated by the potential German announcement of 52 billion euros in defense spending. Renault falls even further, losing 2.44%, while Vinci drops by 2.12%, hit by a recommendation downgrade from Exane BNP Paribas. These last two stocks illustrate how analyst revisions are now structuring trading sessions: Euronext is down 1.56%, Accor 1.39%, and Hermès 1.37%, indicating a gradual shift of liquidity towards stocks with the best catalysts. The luxury sector is losing steam with LVMH declining by 0.62%. In this selective environment, even traditionally defensive stocks don't escape notice: Orange is down 0.87%, Veolia Environnement 0.85%, and Engie 0.55%. However, the extent of the declines and their relative moderation suggest that no panic is prevailing, with pullbacks remaining controlled and aligning with a strategy of repositioning before the weekly close and, more importantly, ahead of expected strategic directions from the US Federal Reserve.